New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2013
07:12 EDTTFXTeleflex awarded agreement with Novation
Teleflex has announced it has been awarded a new three-year agreement with Novation for its line of Weck Vista Access products. The agreement is effective April 1 through March 31, 2016. The Weck Vista Bladeless Laparoscopic Access Ports provide a broad range of sizes and include standard and optical ports that offer both smooth and ridged cannulas, balloon and cone open access ports, reusable obturators for cannula only options and insufflation needles. By offering a complete line of access products, Teleflex provides surgeons who perform minimally invasive procedures access to a broad range of tools that are designed to help increase visualization and stability during procedures.
News For TFX From The Last 14 Days
Check below for free stories on TFX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2014
07:03 EDTTFXTeleflex raises FY14 adjusted EPS view to $5.45-$5.60 from $5.35-$5.55
Consensus is $5.51. Reaffirms FY constant currency revenue growth guidance range of 7% to 9%, consensus $1.82B.
07:02 EDTTFXTeleflex reports Q2 adjusted EPS $1.51, consensus $1.34
Subscribe for More Information
July 29, 2014
07:07 EDTTFXTeleflex receives FDA clearnce for 150cm length Arrow GPSCath catheters
Subscribe for More Information
July 28, 2014
07:03 EDTTFXTeleflex announces European launch of LMA SureSeal PreCurved
Subscribe for More Information
July 23, 2014
17:01 EDTTFXTeleflex signs new agreement with Amerinet for manual ligation products
Subscribe for More Information
07:08 EDTTFXTeleflex signs new agreement with Amerinet
Subscribe for More Information
July 22, 2014
07:04 EDTTFXTeleflex granted FDA clearance for ARROW-Clark VectorFlow Catheter
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use